The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 22, 2008

Filed:

Oct. 16, 2003
Applicants:

Mark Czekaj, Doylestown, PA (US);

Scott I. Klein, Collegeville, PA (US);

Heinz W. Pauls, Oakville, CA;

Inventors:

Mark Czekaj, Doylestown, PA (US);

Scott I. Klein, Collegeville, PA (US);

Heinz W. Pauls, Oakville, CA;

Assignee:

Aventis Pharmaceuticals Inc., Bridgewater, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61P 9/00 (2006.01); A61K 31/517 (2006.01); A61K 31/44 (2006.01); A61K 31/47 (2006.01); A61K 31/415 (2006.01); A61K 31/40 (2006.01); C07D 239/00 (2006.01); C07D 401/00 (2006.01); C07D 217/00 (2006.01); C07D 403/00 (2006.01); C07D 207/00 (2006.01); C07D 405/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

This invention is directed to N-acylpyrrolidin-2-ylalkylbenzamidine derivatives which useful for inhibiting the activity of Factor Xa, by contacting said derivatives with a composition containing Factor Xa. The present invention is also directed to compositions containing said derivatives, methods for their preparation, their use, such as in inhibiting the formation of thrombin or for treating a patient suffering from, or subject to, a disease state associated with a physiologically detrimental excess amount of thrombin.


Find Patent Forward Citations

Loading…